DHFR and pancreatic neoplasm: Similarly, studies on pancreatic cancer cells have demonstrated that low levels of TS, DHFR and GARFT make cells more sensitive to MTA treatment, whereas a lower sensitivity could be explained by the higher expression of the MTA targets [14].